Lihua Budde

Associate Professor

City Of Hope National Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (14)

Matthew Mei

Associate Professor

City of Hope

UNITED STATES

View details

Sagar Patel

Assistant Professor

University of Utah

UNITED STATES

View details

Nizar M Tannir

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Monica Saumoy

University of Pennsylvania

UNITED STATES

View details

James Godfrey

Assistant Professor

City of Hope

UNITED STATES

View details

Adam Olszewski

Associate Professor of Medicine

Rhode Island Hospital

UNITED STATES

View details

Laurie H. Sehn

CANADA

View details

Francesc Bosch

Professor

Universitat Autònoma de Barcelona Facultat de Medicina

SPAIN

View details

Michael Hurwitz

Assistant Professor

Yale University School of Medicine

UNITED STATES

View details

Matthew Matasar

Rutgers Cancer Institute of New Jersey

UNITED STATES

View details

Craig Portell

Associate Professor of Medicine

University of Virginia

UNITED STATES

View details

Catherine Diefenbach

Assistant Professor of Medicine

NYU School of Medicine

UNITED STATES

View details

Sung‐Soo Yoon

SOUTH KOREA

View details

Tanya Siddiqi

Associate Professor

City Of Hope National Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lihua Budde

Research Interests

Explore related searches

Contact this professor

Articles (15)

CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma

Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignancies

Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study

Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas

Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial

Pembrolizumab plus vorinostat is highly active in Hodgkin lymphoma, including patients refractory to prior PD-1 blockade

Interferon-γ blockade in CAR T-cell therapy–associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis

Boosting CAR T cells with anti-tumor mRNA vaccines

Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study

Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphoma

Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma

CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma

Dose Finding Study of Ibrutinib and Venetoclax in Relapsed or Refractory Mantle Cell Lymphoma

Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies

ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphoma

Collaborators (14)

Matthew Mei

Sagar Patel

Nizar M Tannir

Monica Saumoy

James Godfrey

Adam Olszewski

Laurie H. Sehn

Francesc Bosch

Michael Hurwitz

Matthew Matasar

Craig Portell

Catherine Diefenbach

Sung‐Soo Yoon

Tanya Siddiqi

Make your next move.